company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3333000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3333000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,343000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,982000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3770000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1141000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1141000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31870000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,35000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12972000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18953000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18953000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17790000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2487000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2487000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,305000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-69916000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,62214000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4528000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4528000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31195000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,94000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12032000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,231000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18850000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18850000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,99000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,99000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,99000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23279000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,240000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12199000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8580000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8580000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50649000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,83000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29453000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21135000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21135000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29658000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1976000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1976000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,174000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,652000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-284000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8428000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5910000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5910000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25230000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,18000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25533000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,193000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,193000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,162000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,162000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,162000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5555000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,138000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,619000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29362000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2772000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2772000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-562000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28307000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,86000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46668000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-24000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17861000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17861000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20678000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11718000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-698000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11020000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3081000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3532000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-451000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,286000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10591000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,152000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,623000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,643000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11736000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11204000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11204000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-404000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75385000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30548000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45216000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45216000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83253000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,83253000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,83253000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26833000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,166000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,867000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,614000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8024000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6878000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6878000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-218000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47776000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-25000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19907000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,25000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28087000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28087000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34922000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,163000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,990000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,746000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7124000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8303000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8303000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-307000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16344000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27334000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-53000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10655000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10655000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,118000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,118000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,118000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2470000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,176000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,655000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1494000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20724000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8909000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8909000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26808000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54731000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,288000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,288000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,288000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19266000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,175000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,639000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,937000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12236000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1912000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1912000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,13000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31470000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35077000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35077000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,966000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,966000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,966000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32199000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,719000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,880000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,611000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9860000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9860000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29111000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-13000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50349000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,32000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20993000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20993000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1625000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1625000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1625000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12758000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,750000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,924000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1491000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10780000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10780000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34767000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,38000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33487000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-32000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1305000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1305000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2661000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2661000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2661000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9424000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10642000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10642000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,156000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,735000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,908000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2036000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10879000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10879000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14949000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35975000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-108000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20729000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20729000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11842000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11842000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,178000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,617000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1653000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-373000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9767000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9767000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-255000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-108907000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,40000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43391000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65731000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65731000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136241000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,136241000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,136241000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,60743000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13381000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13381000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,208000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,977000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2017000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,214000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9965000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9965000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-649000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99430000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41678000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58396000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58396000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,274000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,274000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,274000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-68087000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,217000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1151000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1858000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,550000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12099000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12099000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-269000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32819000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36304000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3216000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3216000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,484000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,484000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,484000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8399000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19444000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19444000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1047000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1632000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1232000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15309000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15309000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-439000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16388000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32760000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-388000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15545000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15545000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1732000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1732000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1732000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1968000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,244000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1011000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2761000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21007000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18183000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18183000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-159221000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,9000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43398000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-116094000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-116094000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,273525000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,273525000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,273525000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,139248000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23987000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23987000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,251000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1568000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3834000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32295000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13961000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13961000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-510000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-127639000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74221000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,16000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53912000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53912000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1759000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1759000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1759000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34435000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34435000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,244000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1732000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,812000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18572000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18572000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-316000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89577000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42009000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,24000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47860000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47860000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,740000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,740000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,740000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-65692000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29315000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29315000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1721000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5303000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15203000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15203000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-828000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72615000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95495000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22052000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22052000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,968000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,968000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,968000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7817000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,276000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1397000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5478000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17098000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29211000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29211000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-741000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-55561000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,126754000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,70255000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,70255000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,62000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,62000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,62000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41106000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,324000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1043000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6406000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18172000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14335000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14335000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2243000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-113927000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,10000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100396000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,108000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15656000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15656000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,936000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,936000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,936000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29055000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,408000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,711000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5475000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-717000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31010000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31010000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-777000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47653000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91626000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,43196000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,43196000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1329000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1329000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1329000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13515000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,445000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,369000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7090000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5130000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31625000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31625000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-347000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81635000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97050000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,92000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15160000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15160000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16402000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78326000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78326000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,489000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,269000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8097000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-77357000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-77357000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1362000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57877000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116085000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56846000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56846000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1531000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1531000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1531000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18980000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,589000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3185000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8465000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-493000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48239000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48239000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-397000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-307155000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94239000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-213313000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-213313000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,502781000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3712000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,506493000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,506493000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,244941000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11125000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11125000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,616000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5029000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12508000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16338000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9310000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9310000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2804000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-79506000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46911000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35392000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35392000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3022000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3022000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3022000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41680000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6894000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6894000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,706000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5058000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13452000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14465000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,40575000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40575000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2377000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-138870000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81853000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59394000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59394000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13219000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,786000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5103000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19879000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22436000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38486000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38486000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-139354000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,18000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84086000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57050000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57050000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16135000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16135000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16135000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-79401000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5913000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5913000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,883000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5228000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11851000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8430000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20479000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20479000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4643000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84722000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54839000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34514000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34514000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6123000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6123000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6123000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7912000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5822000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,50764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1080000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5134000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13070000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,68917000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,68917000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12359000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105213000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72477000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45095000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45095000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29312000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1275000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4862000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13268000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12971000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,50454000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,50454000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6010000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-216673000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116423000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106256000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106256000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1782000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1782000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1782000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-54020000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5822000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-112500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-112500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-171000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,215900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-68900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,51323000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51323000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1752000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4238000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3050000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9912000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,64175000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,64175000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4492000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119621000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,123840000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-269000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-269000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4265000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4265000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4265000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68171000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5822000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,425000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,53789000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53789000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2009000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4489000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,48700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11161000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,97826000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,97826000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3544000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-231189000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,149083000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-85646000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-85646000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13164000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13164000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13164000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25344000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,82000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,34000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2091000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4719000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28499000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33244000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,102553000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,102553000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2812000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-344214000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,180868000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-166158000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-166158000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7284000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7284000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7284000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-56321000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5822000.0
